Skip to content

Yan Wei

3 papers in the library · 179 citations · publishing 2020-2024

Papers

Sort Most recent Most cited

Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis.

Neurobiology of Disease September 1, 2024 Lijia Chang, Yan Wei, Youge Qu et al. 22 citations

Arketamine, the (R)-enantiomer of ketamine, exhibits antidepressant-like effects in mice, though the precise molecular mechanisms remain elusive. It has been shown to reduce splenomegaly and depression-like behaviors in the chronic social defeat stress (CSDS) model of depression. This study investigated whether the spleen contributes to the antidepressant-like effects of arketamine in the CSDS...

Brain Research Bulletin Special Issue: Brain-body communication in health and diseases Brain-spleen axis in health and diseases: a review and future perspective.

Brain Research Bulletin February 1, 2022 Yan Wei, Tong Wang, Lei Liao et al.

The spleen, an important tissue for the immune system, acts as a filter for blood within the immune system. Accumulating evidence suggests that the spleen affects a number of brain functions in health and diseases via immune modulation. Systemic inflammation or chronic social defeat stress (CSDS) can cause splenomegaly in rodents. Interestingly, the new antidepressant arketamine could normalize...

A historical review of antidepressant effects of ketamine and its enantiomers.

Pharmacology, Biochemistry and Behavior February 5, 2020 Yan Wei, Lijia Chang, Kenji Hashimoto 157 citations

The robust antidepressant effects of (R,S)-ketamine are among the most important discoveries in mood research over the last half century. Off-label use of (R,S)-ketamine, which is an equal mixture of (R)-ketamine and (S)-ketamine, has become especially popular in the United States (US) for treatment-resistant depression. On March 5, 2019, the US Food and Drug Administration approved an...